MARKET COMPOSITE
SWAV - ShockWave Medical Inc8:00:00 PM 3/28/2024
Price
$325.63
+ 3.02 (0.94%)
ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company operates in the United States, Germany, rest of Europe, and internationally. ShockWave Medical, Inc. was incorporated in 2009 and is headquartered in Santa Clara, California.
Financials
Quarterly financials
(USD)Dec 2023Q/Q
Revenue203MM+9%
Gross Profit177.7MM+10%
Cost Of Revenue25.3MM+3%
Operating Income43.3MM-1%
Operating Expenses134.4MM-
Net Income44.3MM+27%
R&D42.3MM+7%
G&A24.9MM+16%
Marketing67.2MM+18%
Interest Expense3MM+18%
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news